Podcasts Health JAMA Editors' Summary Interferon 1a for ARDS, Microaxial LVAD vs IABP for Cardiogenic Shock, Abbreviated Breast MRI vs DBT for Breast Cancer Screening, Screening for Cognitive Impairment, and more

Interferon 1a for ARDS, Microaxial LVAD vs IABP for Cardiogenic Shock, Abbreviated Breast MRI vs DBT for Breast Cancer Screening, Screening for Cognitive Impairment, and more

Published: Feb. 25, 2020, 4 p.m.

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 25, 2020 issue